Citogenetička analiza dejstva adrenalina na humane limfocite u kulturi by Đelić, Ninoslav et al.
UDK 619:575.224
CYTOGENETIC ANALYSIS OF THE EFFECTS OF EPINEPHRINE ON CULTURED HUMAN
LYMPHOCYTES
DJELI] N*, DJELI] DIJANA*, SPREMO-POTPAREVI] BILJANA**, MARKOVI] BILJANA* and
@IVKOVI] LADA**
* Faculty of Veterinary Medicine, University of Belgrade,
** Faculty of Pharmacy, University of Belgrade
(Received 2. February, 2003)
Epinephrine can modulate mitotic activity of normal and malig-
nant cells and exhibit genotoxic potential in some test-systems. It is as-
sumed that metabolic conversion of phenolic groups in the catechol
ring of epinephrine leads to the formation of reactive derivatives and su-
peroxide anions, capable of damaging cellular molecules including
DNA. The aim of the present study was to evaluate the cytotoxic and
genotoxic effects of epinephrine on human peripheral blood lympho-
cytes in vitro. The lowest concentration of epinephrine used in these ex-
periments (5x10-10 M) was calculated to be in the range of the physio-
logical blood level of epinephrine in humans. Three experimental con-
centrations corresponded to minimal (2x10-7 M), average (10-6 M) and
maximal (5x10-6 M) therapeutic doses in human medicine. In addition,
the highest concentrations exceeded the maximal therapeutic dose 10-
fold (5x10-5 M) and 30-fold (1.5x10-4 M), respectively. On the basis of
the results obtained it can be concluded that epinephrine had no influ-
ence on the appearance of chromosome aberrations under the de-
scribed experimental conditions. However, mitotic index was signifi-
cantly lower in cultures treated with the three highest concentrations of
epinephrine used in this investigation.
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INTRODUCTION
Epinephrine has been called the hormone of “fight or flight” due to its imme-
diate release under the influence of various stressors. Moreover, there is increas-
ing evidence that stress hormones and neurotransmitters may represent a link
between the immune, endocrine and central nervous systems. The physiological
effects of epinephrine prepare the body for extraordinary physical and mental ex-
ertion. At the biochemical level, specific binding of epinephrine to adrenergic re-
ceptors coupled to heterotrimeric glycoproteins (G-proteins) initiates a cascade
of biochemical and molecular responses inside the cell leading to changes in cel-
lular activity (Sanders, 1995).
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Epinephrine has the highest affinity for  -adrenoceptors. Binding of epi-
nephrine fo  -adrenoceptors activates Gs to stimulate adenylate cyclase. Pharma-
cological and stereochemical investigations revealed that the aromatic catechol
moiety of epinephrine is essential for its agonist activity (Main and Tucker, 1985).
Although data in the literature concerning physiological and biochemical
changes under the influence of epinephrine and other catecholamines in various
mammalian tissues are very abundant, possible genotoxic and mutagenic effects
have been evaluated only in a few studies. Thus, McGregor et al. (1988) examined
the mutagenicity of catecholamines (including epinephrine) in the mouse lym-
phoma L5178Y cell assay. Although, according to their results, epinephrine ex-
pressed some mutagenic potential, it is still not clear whether these results can be
confirmed in other test-systems on mammalian cells.
There are some interesting experimental data that dopamine causes sub-
stantial DNA damage manifested mainly by strand breaks and base modifications
(Graham et al., 1978; Moldeus et al., 1983). This effect is probably caused by do-
pamine oxidative metabolites. Namely, it is conceivable that oxidation of dopa-
mine phenolic groups results in the formation of superoxide anions. This hypothe-
sis is supported by the finding that induction by L-dopamine of DNA strand breaks
in human fibroblasts was inhibited by coincubation with superoxide dismutase
(SOD) (Moldeus et al., 1983).
The aim of the present study was to evaluate mitotic activity and possible cy-
togenetic changes in cultured human lymphocytes treated with a wide range of
epinephrine concentrations. Experimental concentrations of epinephrine were
calculated to correspond the human physiological blood level, the therapeutic
range, and up to 30-fold greater than the therapeutic concentration. Thus, the re-
sults of this investigation should contribute to a better understanding of the ge-
netic risk at a wide range of epinephrine concentrations.
MATERIALS AND METHODS
Test substance and controls. Epinephrine (CAS No., Adrenalin, Jugoreme-
dija, Zrenjanin) was used as the test substance. An acetone solution of N-methyl-
N'-nitro-N-nitrosoguanidine (MNNG) (Sigma Chemical Co., St. Louis, MO) at a fi-
nal concentration of 10-6 M and human recombinant insulin (Inutral HM-100, ICN
Galenika) at concentration 10-8 M, were the positive controls. The negative control
was prepared as a placebo in Jugoremedija (Zrenjanin) as a solution of all com-
pounds in the preparation except the active one – epinephrine.
Lymphocyte culture. Human peripheral blood lymphocyte cultures were
prepared according to a slight modification of the protocol described by Evans
and O'Riordan (1975). Heparinised whole blood samples (0.8 ml) obtained from
three healthy men under 35 years of age were added to vials with 9.2 ml of pre-
warmed Parker 199 medium (Torlak, Belgrade, Yugoslavia) containing 30% of in-
activated calf serum (Serva, Heidelberg, Germany) and 0.04 mg/ml of phytohae-
magglutinin (Murex Diagnostics Ltd., Dartford, England). Cultures were incubated
in the dark for 72 h at 37  0.5oC.
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Treatment. In order to determine experimental concentrations of epineph-
rine comparable to the blood level of epinephrine in treated patients, we con-
sulted a textbook on pharmacology (Reynolds, 1996). Exactly 47 h and 30 min af-
ter the beginning of incubation, epinephrine (Adrenalin, Jugoremedija) was
added to cultivation vials in such amounts to obtain final experimental concentra-
tions of: 5x10-10 M, 2x10-7 M, 10-6 M, 5x10-6 M. 5x10-5 M and 1.5x10-4 M . Positive
and negative control substances were added to separate cultivation vials.
Chromosome preparation and analysis. Two hours before harvesting, colce-
mid (Ciba, Basel, Switzerland) was added to the cultures to achieve a final con-
centration of 0.5  g/ml. After standard chromosome preparation microscopic
slides were stained in 10% Giemsa (Kemika, Zagreb) solution in Gurr buffer (pH
6.8). Mitotic index was determined on 1000 or more cells, whereas the chromo-
some aberrations were analysed on 150 metaphase spreads per experimental
concentration.
In addition to the cytogenetic study, we evaluated the cytotoxic or cytostatic
effects of epinephrine on cultured human lymphocytes on the same microsopic
slides.
Statistical analysis. The obtained data are presented as mean  SE. The sta-
tistical significance of differences between control and treated groups was ana-
lysed by Student's t-test.
RESULTS
The results of the analysis ot mitotic activity in cultures treated with epineph-
rine are presented in Table 1. The control values of MI were 5.98% for untreated
cultures and 5.91% in cultures treated with negative control (the solvent). Epi-
nephrine did not change the mitotic index (MI) significantly at the lower concentra-
tions (5x10-10 M, 2x10-7 M and 10-6 M). However, at higher concentrations of epi-
nephrine there was a significant decrease in MI. In cultures with a final concentra-
tion of epinephrine of 5x10-6 M, MI was lowered to 3.6% (p<0.05), while the con-
centration of 5x10-5 M had a more profound effect decreasing MI by  55% to the
value of 2.7%. Finally, at the highest experimental concentration epinephrine
(1.5x10-4 M) decreased MI by nearly 70% in comparison to untreated cultures
(MI=1.9%, p<0.01). As expected, the positive controls also changed mitotic activ-
ity: the well known mutagen MNNG lowered MI to 3.4% (p<0.01), whereas insulin
elevated MI to 8.9% (p<0.01).
The results of cytogenetic analysis are presented in Table 2. For the sake of
precise comparisons, we analysed exactly 150 mitotic figures for each experimen-
tal point in control and treated cultures. Evidently, epinephrine did not influence
the frequencies of observed chromosomal changes significantly. Only N-methyl-
N'-nitro-N-nitrosogunaidine (MNNG) caused a significant increase of numeric
chromosome aberrations (aneuploidies and polyploidies), as well as chromoso-
mal gaps and breaks indicating structural changes. The genotoxic effect of MNNG
was most profound here as 15.3% of observed cells contained gaps and breaks.
As usual, the frequency of aneuploid cells was higher than both the frequency of
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polyploid cells and cells with chromosomal gaps and breaks, probably due to the
unavoidable loss of chromosomes during the preparation of metaphase spreads.
Table 1. Influence of epinephrine on mitotic index of cultured human lymphocytes





Untreated 2224 5.98 100.00
Negative control (solvent) 2133 5.91 98.83
10-6 M MNNG 2056 3.36** 59.20**
10-8 M insulin 2570 8.95** 149.67**
Epinephrine 5x10-10 M 2011 4.87 81.44
Epinephrine 2x10-7 M 2298 5.05 84.45
Epinephrine 10-6 M 2478 5.69 95.15
Epinephrine 5x10-6 M 2331 3.60* 60.20*
Epinephrine 5x10-5 M 2060 2.67** 44.65**
Epinephrine 1.5x10-4 M 1828 1.86** 31.10**
MNNG- N-methyl-N'-nitro-N-nitrosoguanidine; *p<0.05; **p<0.01; (Student's t-test)













Untreated 150 4 2.67 1 0.67 4 2.67
Negative control (solvent) 150 6 4.00 3 2.00 2 1.33
10-6 M MNNG 150 13 8.67* 7 4.67* 23 15.33***
10-8 M insulin 150 5 3.33 0 0.00 1 0.67
Epinephrine 5x10-10 M 150 5 3.33 1 0.67 2 1.33
Epinephrine 2x10-7 M 150 7 4.67 2 1.33 3 2.00
Epinephrine 10-6 M 150 4 2.67 0 0.00 1 0.67
Epinephrine 5x10-6 M 150 5 3.33 0 0.00 4 2.67
Epinephrine 5x10-5 M 150 8 5.33 1 0.67 3 2.00
Epinephrine 1.5x10-4 M 150 7 4.67 3 2.00 3 2.00
MNNG- N-methyl-N'-nitro-N-nitrosoguanidine; *p<0.05; ***p<0.001; (Student's t-test)
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DISCUSSION
In the last two decades it has been clearly demonstrated that some hor-
mones can exhibit genotoxic and mutagenic effects. Since early epidemiological
investigations have shown a correlation between the prolonged use of steroid hor-
mones and cancer (Goh, 1967), it is not surprising that steroid hormones are the
best studied group. Basic mechanisms underlying the mutagenic action of natural
and synthetic estrogens have been revealed. Interestingly, metabolic conversion
of estrogens leads to the formation of reactive oxygen species and intermediates
capable of covalently damaging DNA (Liehr, 2001). Therefore, estrogens are con-
sidered as complete carcinogens acting both as tumor promoters (increasing cell
proliferation) and tumor initiators (increasing the mutation rate) (Winter and Liehr,
1996).
Despite progress in understanding the molecular mechanisms of estrogen
mutagenesis, data about genotoxicologic effects of nonsteroid hormones and
mediators are scarce. Since hormones are normal compounds in animal and hu-
man bodies, little attention has been paid to their significance in mutation pro-
cesses (Djeli}, 1997).
In this investigation we evaluated the genotoxic and cytotoxic potential of
epinephrine on human lymphocytes in vitro. Bearing in mind that human T and B
lymphocytes contain  -adrenoceptors in the plasma membrane (van Tits et al.,
1990), we assumed that after binding of epinephrine to  -adrenoceptors signal
transduction may contribute to modulation of mitotic activity and/or the appear-
ance of chromosomal changes.
The analysis of chromosome breakage and aberrations in this investigation,
showed that epinephrine had no influence on this cytogenetic manifestation of
mutagenic action. Although McGregor et al. (1988) observed some mutagenic ac-
tion of epinephrine on mouse lymphoma L5178Y cells, they used a test for gene
mutations at the thymidine kinase locus. Namely, despite this mutagenic potential
of epinephrine at the gene level, the effects may be undetectable at a cytogenetic
level.
Metabolic oxidation of phenolic groups of catecholamines is considered as
a keystep in their genotoxic action. Reactive intermediary semiquinone radicals
from dopamine cause oxidative damage to cellular components, while quinones
can react with nucleophilic groups in proteins and DNA (Mason, 1979). On the
other hand, free oxygen species are created during the oxidation of catechol
groups, such as the superoxide anion (O2-.). Superoxide anions appear to cause
chromosome breakage and sister-chromatid exchanges in human lymphocytes
in vitro (Emerit et al., 1982). The abscence of a genotoxic effect at the cytogenetic
level in this study may reflect the relatively weak metabolic capacity of lympho-
cytes with respect to catecholamines.
To determine possible cytotoxic or cytostatic effects of epinephrine, we ana-
lysed mitotic index (MI) for each experimental concentration as well as for con-
trols. The positive control (MNNG) decreased MI by  40%, compared to untreated
cultures, possibly due to arrest of mitosis because of repair of genetic material.
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Additionally, in cells with a relatively high level of genetic damage cytotoxic effects
occur.
Human recombinant insulin at a concentration of 10-8 M was used as the
positive control capable to stimulate cultured lymphocyte proliferation (Djeli} and
Soldatovi}, 1997). It should be mentioned that insulin has expressed a maximal
effect at the same or very similar concentrations in a number of studies. For exam-
ple, insulin increased malic enzyme gene expression at 0.4x10-8 M in rat differenti-
ating brown adipocytes (Garcia-Jiminez et al., 1993), maximally stimulates DNA
synthesis in mouse embryonic fibroblastic 3T3-F442A preadipose cells at 0.5x10-8
M (Tang et al., 1995), and rapidly decreases the amount of IGF-1-binding protein
mRNA in human HepG2 cells at 10-8 M.
The available data suggest that the epinephrine-induced increase in intra-
cellular cAMP can modulate mitotic activtiy of various cell types. Intracellular
cAMP concentrations increase transiently prior to DNA synthesis in such different
cells as bacteria, yeasts and mammalian cells (Bronstad et al., 1983). Hormone-
specific stimulation of adenylate cyclase elevates intracellular cAMP in regenerat-
ing rat liver hepatocytes (Boynton and Whitfeld, 1981). Moreover, the growth re-
sponse of hepatocytes is facilitated by  -adrenergic stimulation and subsequent
increase of cAMP inside the cell (Friedman et al., 1981). However, some experi-
mental findings indicate that cAMP has dual effects on hepatocyte proliferation –
stimulative effects early in the prereplicative period (G0 and early G1), and a
marked inhibition after the transition from G1 to S phase ( Sand et al., 1992). It is
worth noting that during hepatocarcinogenesis  -adrenoceptors increase in
number and responsiveness to isoproterenol (Refsnes et al., 1986).
The interference of lymphocyte proliferation obtained in cultures treated
with high concentrations of epinephrine is in accordance with the observation that
stimulation of  -adrenoceptors accompanied by elevated intracellular cAMP con-
centration suppresses lymphocyte proliferation (Bourne et al., 1974; Dell'Orco et
al., 1977). Moreover, Cook and McCormick (1993) have shown that cAMP inter-
feres with mitogenic signal transduction in Rat1 cells. Likewise, cAMP inhibits
growth in soft agar of mouse lung tumour cell lines (Droms, 1996).
Therefore, according to available data, cAMP can act both as a stimulator
and an inhibitor of mitogenesis, depending on the cell type or phase of the cell cy-
cle. In the present study epinephrine inhibited lymphocyte proliferation (p<0.05)
at the concentration 5x10-6 M, which is comparable to the maximal therapeutic
dose in human medicine. At concentrations of 5x10-5 M and 1.5x10-4 M the inhibi-
tion was more profound (p<0.01), and greater than the cytotoxic effects of the
positive control.
In light of the experimental data obtained in this study it can be concluded
that epinephrine did not exhibit genotoxic effects. However, high experimental
concentrations of epinephrine interfere with lymphocyte proliferation in vitro.
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CITOGENETI^KA ANALIZA DEJSTVA ADRENALINA NA HUMANE LIMFOCITE U
KULTURI
DJELI] N, DJELI] DIJANA, SPREMO-POTPAREVI] BILJANA, MARKOVI] BILJANA i
@IVKOVI] LADA
SADR@AJ
Adrenalin mo`e da promeni mitotsku aktivnost normalnih i malignih }elija.
Pored toga, adrenalin ispoljava genotoksi~ne efekte u nekim test-sistemima.
Smatra se da metaboli~ka konverzija fenolnih grupa u kateholnom prstenu adre-
nalina dovodi do stvaranja reaktivnih derivata i superoksidnih anjona sposobnih
da o{tete molekule u }eliji, uklju~uju}i DNK. Cilj ovog istra`ivanja bio je da se izvr{i
evaluacija citotoksi~nih i genotoksi~nih efakata adrenalina na limfocite periferne
krvi ~oveka in vitro. Najni`a eksperimentalna koncentracija adrenalina kori{}ena u
ovom eksperimentu (5x10-10 M) prora~unata je tako da bude uporedljiva sa
fiziolo{kom koncentracijom adrenalina u krvi ~oveka. Tri eksperimentalne kon-
centracije odgovaraju minimalnim (2x10-7 M), srednjim (10-6 M) i maksimalnim
(5x10-6 M) terapijskim dozama u humanoj medicini. Pored toga, dve najvi{e kon-
centracije ve}e su od maksimalne terapijske doze deset (5x10-5 M) i trideset puta
(1.5x10-4 M). Na osnovu dobijenih rezultata mo`e se zaklju~iti da adrenalin nije
zna~ajno uticao na pojavu hromozomskih aberacija pod opisanim eksperimental-
nim uslovima. Me|utim, tri najvi{e koncentracije adrenalina upotrebljene u ovom
eksperimentu dovode do zna~ajnog smanjenja mitotske aktivnosti.
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